Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zepp Health (ZEPP) Treasury Shares: 2015-2024

Historic Treasury Shares for Zepp Health (ZEPP) over the last 4 years, with Dec 2024 value amounting to $15.0 million.

  • Zepp Health's Treasury Shares rose 16.46% to $15.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $15.0 million, marking a year-over-year increase of 16.46%. This contributed to the annual value of $15.0 million for FY2024, which is 16.46% up from last year.
  • Per Zepp Health's latest filing, its Treasury Shares stood at $15.0 million for FY2024, which was up 16.46% from $12.9 million recorded in FY2023.
  • Zepp Health's 5-year Treasury Shares high stood at $2.9 million for FY2023, and its period low was $411,795 during FY2021.
  • Its 3-year average for Treasury Shares is $1.7 million, with a median of $1.9 million in 2022.
  • Data for Zepp Health's Treasury Shares shows a peak YoY skyrocketed of 184.65% (in 2022) over the last 5 years.
  • Zepp Health's Treasury Shares (Yearly) stood at $3.4 million in 2021, then soared by 184.65% to $9.7 million in 2022, then soared by 32.20% to $12.9 million in 2023, then grew by 16.46% to $15.0 million in 2024.